TY  - JOUR

T1  - Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial

JO  - eClinicalMedicine

UR  - http://dx.doi.org/10.1016/j.eclinm.2024.102624

PY  - 2024/05/03

AU  - Hansen MS

AU  - Wölfel EM

AU  - Jeromdesella S

AU  - Møller J-JK

AU  - Ejersted C

AU  - Jørgensen NR

AU  - Eastell R

AU  - Hansen SG

AU  - Frost M

ED  - 

DO  - DOI: 10.1016/j.eclinm.2024.102624

PB  - Elsevier BV

VL  - 72

SP  - 102624

EP  - 102624

Y2  - 2024/12/23

ER  -